Granules India Q1 net surges 60% to ₹180 cr on higher revenue
Granules India | Photo Credit: The Hindu Generic drugmaker Granules India reported 60% year-on-year (YoY) surge in net profit to ₹179.96 crore on higher revenues from operations. in the first quarter (Q1) of FY2027. Growth in the contribution of complex generics and from Europe and rest of world markets boosted the revenue by 22% YoY…
Read More “Granules India Q1 net surges 60% to ₹180 cr on higher revenue” »
